Pantoloc Control
·
- Prescription status not stated
- Digestion, stomach, diabetes and nutrition
- Active substance
- Pantoprazole
- Made by
- Takeda GmbH
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
- Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.
From the official label · 2026-09-30 · European Medicines Agency
How it works
This product’s leaflet is published as a scanned document. This section quotes the US prescribing label for the same active substance (pantoprazole sodium). It describes the substance, not this Bulgarian product — its uses and doses can differ.
Pantoprazole is a PPI that suppresses the final step in gastric acid production by covalently binding to the (H +, K + )-ATPase enzyme system at the secretory surface of the gastric parietal cell.
This effect leads to inhibition of both basal and stimulated gastric acid secretion, irrespective of the stimulus.
Pantoprazole is extensively metabolized in the liver through the cytochrome P450 (CYP) system.
After a single oral or intravenous dose of 14 C-labeled pantoprazole to healthy, normal metabolizer subjects, approximately 71% of the dose was excreted in the urine, with 18% excreted in the feces through biliary excretion.
Administration of pantoprazole sodium delayed-release tablets with food may delay its absorption up to 2 hours or longer; however, the C max and the extent of pantoprazole absorption (AUC) are not altered.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-06-05
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
BulgariaNo exact match for this strength and form
SpainNo exact match for this strength and form
CanadaNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Takeda GmbH |
|---|---|
| Active substance | Pantoprazole |
| Used in | Digestion, stomach, diabetes and nutrition |
| Classification | A02BC02 · Digestion, stomach, diabetes and nutrition |
| Authorised on | 2009-06-11 |
| Last updated by the regulator | 2022-01-18 |
| EMA product number | EMEA/H/C/001100 |
Source: European Medicines Agency — medicine data · 2026-09-30 · not reviewed by a clinician
Source: European Medicines Agency (EMA). Product information as published by EMA. Reuse terms: EMA legal notice (reproduction authorised).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.